PMID- 35871312
OWN - NLM
STAT- MEDLINE
DCOM- 20230302
LR  - 20230317
IS  - 2045-7634 (Electronic)
IS  - 2045-7634 (Linking)
VI  - 12
IP  - 4
DP  - 2023 Feb
TI  - Impact of U.S. Preventive Services Task Force lung cancer screening update on 
      drivers of disparities in screening eligibility.
PG  - 4647-4654
LID - 10.1002/cam4.5066 [doi]
AB  - BACKGROUND: In 2021, the U.S. Preventive Services Task Force (USPSTF) updated its 
      recommendation to expand lung cancer screening (LCS) eligibility and mitigate 
      disparities. Although this increased the number of non-White individuals who are 
      eligible for LCS, the update's impact on drivers of disparities is less clear. 
      This analysis focuses on racial disparities among Black individuals because 
      members of this group disproportionately share late-stage lung cancer diagnoses, 
      despite typically having a lower intensity smoking history compared to 
      non-Hispanic White individuals. METHODS: We used data from the National Health 
      Interview Survey to examine the impact of the 2021 eligibility criteria on racial 
      disparities by factors such as education, poverty, employment history, and 
      insurance status. We also examined preventive care use and reasons for delaying 
      medical care. RESULTS: When comparing Black individuals and non-Hispanic White 
      individuals, our analyses show significant differences in who would be eligible 
      for LCS: Those who do not have a high school diploma (28.7% vs. 17.0%, 
      p = 0.002), are in poverty (26.2% vs. 14.9%, p < 0.001), and have not worked in 
      the past 12 months (66.5% vs. 53.9%, p = 0.009). Further, our analyses also show 
      that more Black individuals delayed medical care due to not having transportation 
      (11.1% vs. 3.6%, p < 0.001) compared to non-Hispanic White individuals. 
      CONCLUSIONS: Our results suggest that despite increasing the number of Black 
      individuals who are eligible for LCS, the 2021 USPSTF recommendation highlights 
      ongoing socioeconomic disparities that need to be addressed to ensure equitable 
      access.
CI  - (c) 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
FAU - Maki, Kristin G
AU  - Maki KG
AUID- ORCID: 0000-0003-2980-7118
AD  - Department of Health Services Research, University of Texas MD Anderson Cancer 
      Center, Houston, Texas, USA.
FAU - Talluri, Rajesh
AU  - Talluri R
AD  - Department of Data Science, University of Mississippi Medical Center, Jackson, 
      Mississippi, USA.
FAU - Toumazis, Iakovos
AU  - Toumazis I
AUID- ORCID: 0000-0002-3462-2137
AD  - Department of Health Services Research, University of Texas MD Anderson Cancer 
      Center, Houston, Texas, USA.
FAU - Shete, Sanjay
AU  - Shete S
AUID- ORCID: 0000-0001-7622-376X
AD  - Department of Biostatistics, University of Texas MD Anderson Cancer Center, 
      Houston, Texas, USA.
AD  - Department of Epidemiology, University of Texas MD Anderson Cancer Center, 
      Houston, Texas, USA.
AD  - Division of Cancer Prevention and Population Sciences, University of Texas MD 
      Anderson Cancer Center, Houston, Texas, USA.
FAU - Volk, Robert J
AU  - Volk RJ
AUID- ORCID: 0000-0001-8811-5854
AD  - Department of Health Services Research, University of Texas MD Anderson Cancer 
      Center, Houston, Texas, USA.
LA  - eng
GR  - P30CA016672/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20220724
PL  - United States
TA  - Cancer Med
JT  - Cancer medicine
JID - 101595310
SB  - IM
MH  - Humans
MH  - *Lung Neoplasms/diagnosis/epidemiology
MH  - Early Detection of Cancer/methods
MH  - Racial Groups
MH  - Surveys and Questionnaires
MH  - Preventive Health Services
MH  - Mass Screening
PMC - PMC9972155
OTO - NOTNLM
OT  - cancer screening eligibility
OT  - disparities
OT  - early detection
OT  - health services research
OT  - lung cancer screening
COIS- The authors do not have conflicts of interest to report.
EDAT- 2022/07/25 06:00
MHDA- 2023/03/03 06:00
PMCR- 2022/07/24
CRDT- 2022/07/24 07:52
PHST- 2022/07/06 00:00 [revised]
PHST- 2022/05/11 00:00 [received]
PHST- 2022/07/13 00:00 [accepted]
PHST- 2022/07/25 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
PHST- 2022/07/24 07:52 [entrez]
PHST- 2022/07/24 00:00 [pmc-release]
AID - CAM45066 [pii]
AID - 10.1002/cam4.5066 [doi]
PST - ppublish
SO  - Cancer Med. 2023 Feb;12(4):4647-4654. doi: 10.1002/cam4.5066. Epub 2022 Jul 24.